Diagnosis and therapy of cancer using SGP28-related molecules
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 28, 2004
Grant Date -
N/A
app pub date -
Oct 27, 2000
filing date -
Oct 28, 1999
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to methods and compositions for the diagnosis and therapy of prostate cancer which utilize isolated polynucleotides corresponding to the human SGP28 gene, proteins encoded by the SGP28 gene and fragments thereof, and antibodies capable of specifically recognizing and binding to SGP28 proteins.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully